Perioral dermatitis
☆ AI Dermatology — Free Service
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Papules ni ayika ẹnu ati iho imu, pẹlu diẹ ninu awọn pupa ti a le ri gẹgẹ bi patch tabi pustule ni ayika ẹnu.
relevance score : -100.0%
ReferencesPerioral dermatitis jẹ ipo awọ ara ti ko dara ti o wọpọ jùlọ laarin awọn ọdọ, ti a ṣe afihan nipasẹ awọn àkúnya pupa kékeré tàbí awọn àbùlé gbigbẹ, pẹ̀lú awọ didan ní ayíká ẹnu. Bí ó tilẹ̀ jẹ́ pé ó máa ń kan àgbègbè tó wà ní ayíká ẹnu, ó tún lè hàn ní pápá àwọn ojú àti imu, èyí tó yọrí sí orúkọ míì rẹ̀, periorificial dermatitis. Lílò àwọn corticosteroid amúṣantóbi lórí ojú lè fa àìlera yìí, nítorí náà ìgbésẹ̀ àkọ́kọ́ ní ìtọ́jú ni láti dáwọ́ lílò àwọn corticosteroid wọ̀nyí. Àwọn aṣàyàn ìtọ́jú míì ni lílò metronidazole tó wà ní àgbègbè, tàbí àwọn calcineurin inhibitors, tàbí mímú egboogi tetracycline ní ẹnu. Perioral dermatitis máa ń dáhùn dáadáa sí ìtọ́jú, ṣùgbọ́n ó lè máa wà nípò àìlera fún àkókò kan tàbí tún bọ̀ padà nígbà míì.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Propolis jẹ nkan lipophilic ti a fa jade lati inu awọn irugbin nipasẹ awọn oyin. Idi ti ijabọ ọran yii ni lati ṣafihan pataki nkan yii gẹgẹbi idi ti cheilitis olubasọrọ aleji. Alaisan obinrin ọmọ ọdun 21 ro pe o ti ni àléfọ perioral ti o n dun fun ọdun marun. Ni awọn oṣu to kọja, o tun kan ọrun. Lẹhin ti ṣe iwadii dermatitis olubasọrọ, a fi silẹ si idanwo aleji kan. Abajade idanwo aleji jẹ rere, pẹlu agbara to ga fun propolis (++) .
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Orisirisi awọn arun ara iredodo ti a ṣe apejuwe nipasẹ awọn papules erythematous. Awọn arun ti o wọpọ julọ ni folliculitis ati rosacea; awọn arun pataki ni eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Àwọn ohun èlò tó ní steroid (amúṣantóbi) lè jẹ́ ìdí tí àìlera yìí fi ń hàn, tí àwọn ohun ìkúnra tó tutù àti àwọn ohun èlò ìṣọ́ra lè tún ṣe àfikún sí ìdàgbàsókè rẹ̀. Ìtọ́jú máa ń bẹ̀rẹ̀ pẹ̀lú fífi àwọn steroid tó wà ní àgbègbè yìí kúrò, àti pípa àwọn ohun ìkúnra kúrò; ní àwọn ọ̀ràn tó ń léwu, a lè fún ní tetracyclines ní ẹnu. Ìdákẹ́jẹ́ àwọn steroid lè fa àìlera náà kí ó bọ́ sí i.
Àìlera yìí ní àkúnya tó tó 0.5–1 % àwọn ènìyàn ní gbogbo ọdún ní ayé. Ọ̀pọ̀ jùlọ (to 90 %) àwọn tí ó ní í jẹ́ àwọn obìnrin tó wà láàárín ọdún 16 sí 45.
○ Itọju – Oògùn OTC
Perioral dermatitis sábà máa ń wáyé nítorí ìfarapa tó ń bọ́ láti ohun ìkúnra, nítorí náà kò yẹ kí a lo ohun ìkúnra ní àgbègbè ẹnu. Lílò antihistamine OTC lè rànlọ́wọ́. Itọju máa ń gba ọ̀pọ̀ oṣù.
#OTC antihistamine